logo
U.S.-Syria Business Council Launches in Washington, D.C.

U.S.-Syria Business Council Launches in Washington, D.C.

Council Convenes First-Ever High-Level Syria Banking Roundtable
WASHINGTON, June 25, 2025 /PRNewswire/ -- In a landmark step toward rebuilding bilateral commercial and financial ties between the United States and Syria, the U.S.–Syria Business Council (USSBC) has officially launched operations as an independent, nonprofit trade association based in Washington, D.C. The Council's formation comes at a pivotal moment following a high-level meeting between U.S. President Donald J. Trump and Syrian interim President Ahmed Al-Sharaa, during which the White House announced the beginning of sanctions relief and signaled a renewed commitment to constructive engagement.
On the occasion of the Council's historic launch, His Excellency Dr. Nedal Alchaar, Minister of Economy and Industry, stated: 'At a time when we are witnessing remarkable global transformations, we must appreciate and respect the noble stance of the United States of America toward Syria. Syria, which has endured so much due to empty positions and misleading slogans, is now ready to rise from the rubble and return once again as an active partner in building a promising and dignified civilization, just as it has been for thousands of years.'
In the days following its establishment, the USSBC convened a landmark banking roundtable, gathering senior representatives from over 15 major U.S. and international financial institutions, five of Syria's leading private banks, the Central Bank of Syria, and officials from the United States, United Kingdom, European Union, and United Nations. The session served as a rare and timely forum to begin rebuilding institutional trust and explore pathways for financial reconnection.
'This roundtable marked an important and necessary first step in reopening dialogue between both sides,' said Sameer Saboungi, Attorney, Policy Expert, and Founding Member of the USSBC. 'It lays the groundwork for restoring confidence in Syria's banking sector, re-establishing correspondent ties, and enabling the responsible flow of capital.'
The USSBC expresses its sincere appreciation to the teams at Foley Hoag LLP and Clifford Chance LLP, as well as Stephen Fallon of DBM Consulting, for their support in organizing the roundtable.
With a mission to accelerate trade, facilitate scientific and professional exchange, and support cross-border investment, the Council will focus on sectors vital to Syria's reconstruction and U.S. global growth. Planned activities include trade missions, investment forums, export-import advisory, and tailored market guidance for companies seeking to operate across either economy.
The Council is led by a Board of Directors and Advisory Board composed of influential leaders in law, finance, technology, and business. Founding members, thus far, include:
'The USSBC is proud to support U.S. companies investing in Syria's recovery and growth. As the first American firm to enter the Syrian telecom sector by launching 4G and 5G services in Northern Syria through FSN Telecom, we understand such ventures exemplify the kind of forward-looking engagement the Council aims to foster,' said Jay Salkini, Founder and CEO of Tecore, and Founding Member of the USSBC. 'We hope this milestone sets the stage for deeper, long-term economic ties between Syria and the United States—grounded in mutual prosperity and opportunity for years to come.'
Issam Ghreiwati, President of the Damascus Chamber of Commerce and Founding Member of the USSBC, emphasized that 'the Council represents a promising economic platform to support Syria's rebuilding phase and will contribute to establishing a solid economic and trade partnership between Damascus and Washington'.
The USSBC invites businesses, investors, and institutions to collaborate in shaping this new chapter of U.S.–Syria economic cooperation. As a trusted platform for knowledge exchange, strategic insight, and sector-specific collaboration, the Council is committed to empowering stakeholders in both countries to unlock long-term economic potential.
To learn more or explore opportunities for involvement, please contact:
[email protected]
www.ussyriabc.org
About the U.S.–Syria Business Council
The U.S.–Syria Business Council (USSBC) is an independent, nonprofit organization based in Washington, D.C., dedicated to fostering bilateral trade, enhancing scientific and professional exchange, and guiding investment between the United States and Syria. Through strategic advisory, targeted initiatives, and cross-border collaboration, the USSBC serves as a trusted platform for empowering U.S. and Syrian businesses to thrive in both markets.
Media Inquiries:
[email protected]
View original content to download multimedia: https://www.prnewswire.com/news-releases/ussyria-business-council-launches-in-washington-dc-302490360.html
SOURCE U.S.-Syria Business Council
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders
Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders

Yahoo

time21 minutes ago

  • Yahoo

Biohaven Ltd. (BHVN) Collaborates with Bexorg, Inc to Target Central Nervous System Disorders

Biohaven Ltd. (NYSE:BHVN) is one of the Best 52-Week Low Stocks to Buy According to Analysts.. On June 10, Biohaven Ltd. (NYSE:BHVN) announced that it has started a research collaboration with Bexorg, Inc. targeting central nervous system disorders. Bexorg, which is a techbio company, has a platform that can revive and study whole human and pig brains using artificial blood. This technology helps them see how drugs affect actual brain tissue. The platform produces deep data about how genes and proteins behave in disease and health. A pharmacist in a white coat with a range of drugs on shelves behind her. Both companies will use this technology to help design and test new therapies for CNS conditions. As a result of this collaboration, two Biohaven Ltd. (NYSE:BHVN) preclinical programs will benefit from these unique brain studies. Bexorg's approach offers a big leap ahead of normal lab models. Biohaven Ltd. (NYSE:BHVN) is a biopharmaceutical company that develops and commercializes treatments for diseases in immunology, neuroscience, and oncology. While we acknowledge the potential of BHVN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Sparrow expands coverage to five U.S. states, making it easier than ever for Americans to claim missing money
Sparrow expands coverage to five U.S. states, making it easier than ever for Americans to claim missing money

Yahoo

time21 minutes ago

  • Yahoo

Sparrow expands coverage to five U.S. states, making it easier than ever for Americans to claim missing money

Now available in Pennsylvania, Sparrow expands its secure, automated missing money platform to five states — with more on the way NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) -- Sparrow, the secure platform that helps Americans claim missing money in minutes, has officially expanded to five states — with Pennsylvania the newest addition. The company's fully automated service now supports residents in California, Texas, Wisconsin, Nebraska, and Pennsylvania, with additional support for Georgia and Florida coming soon. With over $80 billion in unclaimed funds sitting idle — and 1 in 7 Americans estimated to have missing money — Sparrow offers a fast, safe, and frustration-free way to recover what's rightfully yours. Using cutting-edge technology and real-time financial data, Sparrow verifies your identity, retrieves the necessary documents on your behalf, and prepares your claim with minimal effort required. What used to take days — and often involved printing, mailing, or even visiting a notary — now takes most users under five minutes. 'We built Sparrow because the process of claiming lost money felt unnecessarily hard for everyday people,' said Will Nemirovsky, CEO. 'I ran into it myself in 2024, trying to claim a small refund — and it took hours of paperwork and frustration. We knew we could make it effortless and secure using modern technology and automation. Expanding to Pennsylvania is especially meaningful for me —it's where I met my Co-Founder, Jack Goettle.' Sparrow is fully licensed, offers risk-free pricing, and is committed to bank-grade encryption and secure data handling. Claims are processed through streamlined workflows that minimize human error and eliminate guesswork. Behind the scenes is a team of fintech veterans working to modernize a system that has failed everyday consumers for decades. To date, Sparrow has already helped users reclaim millions of dollars — and they're just getting started. Sparrow offers a success-based model: if your claim isn't paid, you don't pay. Check if you're owed money — it only takes a few minutes. Visit to get started. media@ Photos accompanying this announcement are available at: in to access your portfolio

Bank of America Securities Reiterated a Buy Rating on Ultragenyx Pharmaceutical (RARE)
Bank of America Securities Reiterated a Buy Rating on Ultragenyx Pharmaceutical (RARE)

Yahoo

time21 minutes ago

  • Yahoo

Bank of America Securities Reiterated a Buy Rating on Ultragenyx Pharmaceutical (RARE)

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On July 14, Tazeen Ahmad from Bank of America Securities reiterated a Buy rating on Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), while lowering the price target from $80 to $79. The firm held its positive outlook even after the recent challenge from the FDA's complete response letter for UX111 in Sanfilippo syndrome. The CRL was focused on specific chemistry, manufacturing, and controls issues. Importantly, the clinical data for UX111 was not questioned; however, the approval is still achievable once the CMC issues are resolved. A research team in a laboratory peering through microscopes at a biologic product. The analyst noted that the company is responding quickly and plans to address the CMC concerns and resubmit its Biologics License Application in the coming months. The analyst is also optimistic due to Ultragenyx Pharmaceutical Inc.'s (NASDAQ:RARE) robust pipeline. The company has promising programs for conditions like osteogenesis imperfecta and Angelman syndrome. Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) develops treatments for rare and ultra-rare genetic diseases. They focus on biologics, small molecules, gene therapy, and nucleic acid products. While we acknowledge the potential of RARE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store